XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements Of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Preferred shares
Common shares
Treasury shares
Additional Paid-in capital
Accumulated other comprehensive (loss) income
Retained earnings
Retained earnings
Cumulative Effect Period of Adoption Adjustment
Total Textainer Group Holdings Limited shareholders' equity
Total Textainer Group Holdings Limited shareholders' equity
Cumulative Effect Period of Adoption Adjustment
Noncontrolling interest
Noncontrolling interest
Cumulative Effect Period of Adoption Adjustment
Beginning Balances at Dec. 31, 2018 $ 1,235,991     $ 581 $ (9,149) $ 406,083 $ (436) $ 809,734   $ 1,206,813   $ 29,178  
Beginning Balances (in shares) at Dec. 31, 2018       58,032,164 (630,000)                
Dividends paid to noncontrolling interest (2,744)                     (2,744)  
Purchase of treasury shares (8,597)       $ (8,597)         (8,597)      
Purchase of treasury shares (in shares)         (878,637)                
Restricted share units vested       $ 2   (2)              
Restricted share units vested (in shares)       281,377                  
Exercise of share options $ 126         126       126      
Exercise of share options (in shares) 13,014     13,014                  
Share-based compensation expense $ 4,388         4,388       4,388      
Net income 56,556             56,724   56,724   (168)  
Other comprehensive income (loss):                          
Change in derivative instruments designated as cash flow hedges (110)           (110)     (110)      
Reclassification of realized gain on derivative instruments designated as cash flow hedges (7)           (7)     (7)      
Foreign currency translation adjustments 42           42     42      
Total other comprehensive income (loss) (75)                        
Ending Balances at Dec. 31, 2019 1,285,645     $ 583 $ (17,746) 410,595 (511) 866,458   1,259,379   26,266  
Ending Balances (ASU 2016-13) at Dec. 31, 2019   $ (892)             $ (885)   $ (885)   $ (7)
Ending Balances (in shares) at Dec. 31, 2019       58,326,555 (1,508,637)                
Purchase of treasury shares $ (68,493)       $ (68,493)         (68,493)      
Purchase of treasury shares (in shares) (6,736,493)       (6,736,493)                
Restricted share units vested       $ 3   (3)              
Restricted share units vested (in shares)       300,404                  
Exercise of share options $ 1,295     $ 1   1,294       1,295      
Exercise of share options (in shares) 113,960     113,960                  
Share-based compensation expense $ 4,723         4,723       4,723      
Net income 73,673             72,822   72,822   851  
Other comprehensive income (loss):                          
Change in derivative instruments designated as cash flow hedges (12,307)           (12,307)     (12,307)      
Reclassification of realized gain on derivative instruments designated as cash flow hedges 2,806           2,806     2,806      
Foreign currency translation adjustments 177           177     177      
Income tax benefit related to items of other comprehensive loss 91           91     91      
Total other comprehensive income (loss) (9,233)                        
Ending Balances at Dec. 31, 2020 1,286,718     $ 587 $ (86,239) 416,609 (9,744) 938,395   1,259,608   27,110  
Ending Balances (in shares) at Dec. 31, 2020       58,740,919 (8,245,130)                
Purchase of treasury shares $ (72,220)       $ (72,220)         (72,220)      
Purchase of treasury shares (in shares) (2,426,725)       (2,426,725)                
Issuance of preferred shares, net of offering expenses $ 289,580   $ 300,000     (10,420)       289,580      
Issuance of preferred shares, net of offering expenses (in shares)     12,000                    
Restricted share units vested       $ 3   (3)              
Restricted share units vested (in shares)       285,688                  
Exercise of share options $ 9,043     $ 5   9,038       9,043      
Exercise of share options (in shares) 477,103     477,103                  
Share-based compensation expense $ 6,699         6,699       6,699      
Purchase of noncontrolling interest (20,088)         7,022       7,022   $ (27,110)  
Preferred shares dividends declared (9,975)             (9,975)   (9,975)      
Dividends declared to common shareholders ($0.25per common share) (12,285)             (12,285)   (12,285)      
Net income 284,288             284,288   284,288      
Other comprehensive income (loss):                          
Change in derivative instruments designated as cash flow hedges 10,986           10,986     10,986      
Reclassification of realized gain on derivative instruments designated as cash flow hedges 8,771           8,771     8,771      
Foreign currency translation adjustments (79)           (79)     (79)      
Income tax benefit related to items of other comprehensive loss (184)           (184)     (184)      
Total other comprehensive income (loss) 19,494                        
Ending Balances at Dec. 31, 2021 $ 1,781,254   $ 300,000 $ 595 $ (158,459) $ 428,945 $ 9,750 $ 1,200,423   $ 1,781,254      
Ending Balances (in shares) at Dec. 31, 2021     12,000 59,503,710 (10,671,855)